|

IBI3020 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.1

Indications

  • Solid Tumors1
  • Cancer1

Pheonix, Arizona1 trial

Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors

Mayo Clinic - Arizona

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.